ceefourin-1 and Carcinoma--Pancreatic-Ductal

ceefourin-1 has been researched along with Carcinoma--Pancreatic-Ductal* in 1 studies

Other Studies

1 other study(ies) available for ceefourin-1 and Carcinoma--Pancreatic-Ductal

Article	Year
Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux. Molecular pharmacology, 2019, Volume: 96, Issue:1 Topics: Benzothiazoles; Carcinoma, Pancreatic Ductal; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Computer Simulation; Cyclic AMP; Gene Expression Regulation, Neoplastic; Gene Silencing; HEK293 Cells; Humans; Multidrug Resistance-Associated Proteins; Pancreatic Neoplasms; Probenecid; Prognosis; Propionates; Quinolines; Signal Transduction; Survival Analysis; Triazoles; Up-Regulation	2019

Article

Year

Identification of MRP4/ABCC4 as a Target for Reducing the Proliferation of Pancreatic Ductal Adenocarcinoma Cells by Modulating the cAMP Efflux.

Molecular pharmacology, 2019, Volume: 96, Issue:1

Topics: Benzothiazoles; Carcinoma, Pancreatic Ductal; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Computer Simulation; Cyclic AMP; Gene Expression Regulation, Neoplastic; Gene Silencing; HEK293 Cells; Humans; Multidrug Resistance-Associated Proteins; Pancreatic Neoplasms; Probenecid; Prognosis; Propionates; Quinolines; Signal Transduction; Survival Analysis; Triazoles; Up-Regulation

2019